NASDAQ · STOCK
GE HealthCare
$64.44
52W $58.75 – $89.77
56/100
$29.82B
15.6
0.82
Price History (6M)
Executive Summary
4 analysts weighed in with 50% agreement on a neutral lean. Macro Analyst: Market regime is bullish (Bull market -- normal position sizing). Growth Analyst: Growth rate is decelerating quarter over quarter -- the trend line matters more than the level. Overall recommendation: WATCH.
Executive Summary
4 analysts weighed in with 50% agreement on a neutral lean. Macro Analyst: Market regime is bullish (Bull market -- normal position sizing). Growth Analyst: Growth rate is decelerating quarter over quarter -- the trend line matters more than the level. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
AI Investment Committee
Committee Consensus
As of July 07, 2026
Overall Committee Score
56/100
Agreement
50%
Analysts
4
Conviction
Contested
Growth Analyst
bearish
35
/ 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Technical Analysis
RSI (14)
52.1
Neutral
MACD Histogram
0.159
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$63.81
Resistance
$75.92
Bollinger %B
0.58
Inside Bands
Price vs Moving Averages
EMA 9
$64.67
Below
EMA 21
$64.31
Above
EMA 50
$65.21
Below
EMA 200
$71.57
Below
Fundamental Analysis
Valuation
83
Growth
29
Profitability
60
Financial Health
62
Valuation
P/E Ratio
15.6×
P/B Ratio
3.60×
PEG Ratio
—
Dividend Yield
0.21%
52W High
$89.77
52W Low
$58.75
Quality & Growth
ROE
1875.0%
ROA
525.0%
Gross Margin
3914.0%
Operating Margin
1263.0%
Revenue Growth YoY
+597.0%
Debt / Equity
0.97
AI Fundamental Assessment
P/E ratio of 15.6 (inexpensive relative to a 15-40x range); Price-to-book of 3.6x; Revenue growth (YoY) of 6.0%; EPS growth (YoY) of -12.3%; Return on equity of 18.8%; Return on assets of 5.2%; Net margin of 9.1%; Gross margin of 39.1%; Current ratio of 1.37 (tight short-term liquidity); Debt-to-equity of 0.97; Most recent quarter missed estimates by 7.5%; EPS growth decelerating (+34.6% -> -31.2% QoQ); Analyst estimates flat over recent quarters
Key Risks
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full GEHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile